![Jaye Thompson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jaye Thompson
Technik-/Wissenschafts-/F&E-Leiter bei
GREENWICH LIFESCIENCES, INC.
Vermögen: 7 Mio $ am 31.05.2026
Profil
Jaye L.
Thompson was the founder of Synergos, Inc., founded in 1991, where the title held was President.
Dr. Thompson was the founder of Proxima Clinical Research, Inc., founded in 2017, where the title held was Chief Operating Officer.
Current jobs include Director at Gulf Coast Regional Center of Innovation & Commercialization since 2013 and Vice President-Clinical & Regulatory Affairs at Greenwich LifeSciences, Inc. since 2019.
Former jobs include Senior Vice President-Clinical & Regulatory at Repros Therapeutics, Inc. from 2013 to 2017, SVP-Clinical Development & Regulatory Affairs at Opexa Therapeutics, Inc. from 2009 to 2013, Advisor at MediGen Group LLC, and SVP-Regulatory Affairs & Emerging Biotechnologies at inVentiv Clinical Solutions LLC in 2009.
Education includes undergraduate degree from Texas A&M University and graduate and doctorate degrees from Texas University of Health Center at San Antonio.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.12.2024 | 264.148 ( 1,91 % ) | 7 Mio $ | 31.05.2026 |
Aktive Positionen von Jaye Thompson
| Unternehmen | Position | Beginn |
|---|---|---|
| GREENWICH LIFESCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2019 |
Gulf Coast Regional Center of Innovation & Commercialization | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jaye Thompson
| Unternehmen | Position | Ende |
|---|---|---|
| REPROS THERAPEUTICS INC | Technik-/Wissenschafts-/F&E-Leiter | - |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2013 |
inVentiv Clinical Solutions LLC
 inVentiv Clinical Solutions LLC Medical DistributorsDistribution Services Part of Syneos Health, Inc., inVentiv Clinical Solutions LLC is a company based in Houston, TX. The CEO of the company is Mike Hlinak. | General Counsel | 01.01.2009 |
Proxima Clinical Research, Inc.
 Proxima Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical research company that develops biotech products | Gründer | - |
Synergos, Inc.
 Synergos, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical trial management services | Gründer | - |
Ausbildung von Jaye Thompson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
18
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat hormonal and reproductive system disorders | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synergos, Inc.
Synergos, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical trial management services | Commercial Services |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
MediGen Group LLC
 MediGen Group LLC Investment ManagersFinance MediGen Group provides seed and early-stage capital to new life sciences companies. The firm may fund proof-of-concept experiments and deal conceptualization. Companies should have large growing markets and strong intellectual property. They should also have defined regulatory paths to accelerate product development and mitigate FDA approval risk. MediGen seeks investments in companies with a clear path to monetization with substantial short-term value-creating milestones that allow for multiple exit opportunities and hedges against developmental setbacks | Finance |
Texas University of Health Center at San Antonio
 Texas University of Health Center at San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
inVentiv Clinical Solutions LLC
inVentiv Clinical Solutions LLC Medical DistributorsDistribution Services Part of Syneos Health, Inc., inVentiv Clinical Solutions LLC is a company based in Houston, TX. The CEO of the company is Mike Hlinak. | Distribution Services |
Gulf Coast Regional Center of Innovation & Commercialization | |
Proxima Clinical Research, Inc.
Proxima Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical research company that develops biotech products | Commercial Services |
Greenwich LifeSciences, Inc.
 Greenwich LifeSciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapy to prevent breast cancer recurrences | Health Technology |
